T.K.C. reports receiving research support (institutional and personal) from AstraZeneca, Alexion, Bayer, Bristol Myers-Squibb/ER Squibb & Sons, Cerulean, Eisai, Foundation Medicine, Exelixis, Ipsen, Tracon, Genentech, Roche, Roche Products, F. Hoffmann-La Roche, GlaxoSmithKline, Lilly, Merck, ...
expression dynamics during human fetal kidney development, we integrate microarray-based spatial transcriptomics with single-cell RNA-seq on fetal kidney tissues at 9 and 18 weeks using the 10× Genomics platform, giving new perspectives on robust targets for regenerative medicine and kidney organoid ...
History of cell-type classification Limitations of the current methods of cell-type classification Emerging concepts for cell-type classification Proposing a data-driven cell-type definition Cell type authentication for regenerative medicine Guidelines for big data generation, storage, and management Conclusio...
Brought to you by the editorial team of Cell Death & Differentiation, Cell Death & Disease is a peer-reviewed online journal in the field of translational cell death. It seeks to promote diverse and integrated areas of Experimental and Internal Medicine with its specialties, including Cancer, ...
Stem cell therapy holds the promise to treat degenerative diseases, cancer and repair of damaged tissues for which there are currently no or limited therapeutic options. The potential of stem cell therapies has long been recognised and the creation of in
Experimental and therapeutic medicine. 2020;20(2):1105–14. Article CAS PubMed PubMed Central Google Scholar Qiu L, Chen C, Li SJ, Wang C, Guo F, Peszel A, et al. Prognostic values of red blood cell distribution width, platelet count, and red cell distribution width-to-platelet ...
Center for Experimental Medicine, The Third Xiangya Hospital of Central South University, No. 138 Tongzipo Road, Changsha, 410013, China Hongwei Lu Contributions YC, HL, and LJ designed the study. YC, YM, and WF collected and analyzed the data and drafted the manuscript. YM and WF revised ...
Stem Cell Reviews and Reports. 2010, 6: 611-621. 10.1007/s12015-010-9185-7. PubMed Google Scholar Nasef A, Ashammakhi N, Fouillard L: Immunomodulatory effect of mesenchymal stromal cells: Possible mechanisms. Regenerative Medicine. 2008, 3: 531-546. 10.2217/17460751.3.4.531. CAS PubMed ...
Single-cell technologies enable the dynamic analyses of cell fate mapping. However, capturing the gene regulatory relationships and identifying the driver factors that control cell fate decisions are still challenging. We present CEFCON, a network-based
T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins1,2, combined with the Toll-like receptor 1/2 agonist XS15 emulsified